AUVI-Q .3 mg/.3mL
AUVI-Q · INJECTION, SOLUTION · HF Acquisition Co LLC, DBA HealthFirst
No Recall History
Plain English
AUVI-Q is a injection, solution containing auvi-q at .3 mg/.3mL, taken intramuscular. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.
Key Facts
- Brand Name
- AUVI-Q
- Generic Name
- AUVI-Q
- NDC Code (Product)
51662-1663- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Strength
- .3 mg/.3mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- NDA201739
- Drug Class
- alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
- Marketing Start
- 11/15/2012
Recall History
No Recall HistoryFrequently Asked Questions
What is AUVI-Q used for?
AUVI-Q contains AUVI-Q. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is AUVI-Q a controlled substance?
AUVI-Q is not classified as a controlled substance by the DEA.
What is the generic name for AUVI-Q?
The generic name for AUVI-Q is AUVI-Q. There are no other listed brand versions of AUVI-Q.
What is the NDC code for AUVI-Q .3 mg/.3mL?
The NDC (National Drug Code) for AUVI-Q .3 mg/.3mL is 51662-1663, listed by HF Acquisition Co LLC, DBA HealthFirst.
Other AUVI-Q Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)